Nicolas Dumaz

INSERM

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

LinkedIn

Google Scholar

Articles (14)

Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1

Year:

2024

PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors.

Year:

2024

TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro

Year:

2023

Combined PDE4+MEK inhibition shows antiproliferative effects in NRAS Q61 mutated melanoma preclinical models

Year:

2023

Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2.

Year:

2023

Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction

Year:

2022

Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma.

Year:

2022

Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma

Year:

2022

The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.

Year:

2022

RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy

Year:

2021

Mitogen-activated protein kinase blockade in melanoma: intermittent versus continuous therapy, from preclinical to clinical data.

Year:

2021

Mitogen-activated protein kinase blockade in melanoma: Intermittent versus continuous therapy, from preclinical to clinical data

Year:

2021

New perspectives on targeting RAF, MEK and ERK in melanoma.

Year:

2021

New perspectives on targeting RAF, MEK and ERK in melanoma

Year:

2021

Collaborators (1)

Andrey Yurchenko

Institut Gustave Roussy

FRANCE

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI